The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Site-directed Mutagenesis Service Market Research Report 2025

Global Site-directed Mutagenesis Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1739095

No of Pages : 112

Ask Your Query

Synopsis
Global Site-directed Mutagenesis Service market is projected to reach US$ 1353.3 million in 2029, increasing from US$ 974 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Site-directed Mutagenesis Service market research.

Site-directed mutagenesis is a widely used technique in molecular biology and genetic engineering that allows researchers to introduce specific changes or mutations into a DNA sequence.

Site-directed mutagenesis services are provided by various companies and research institutions to support scientific research, drug development, and other applications requiring precise modifications to DNA sequences. These services often involve the design and synthesis of custom DNA templates with specific mutations or modifications requested by the client.

The market status and future development trends of the site-directed mutagenesis service market include the following:
Increasing Demand: With advancements in genetic research and biotechnology applications, there is a growing demand for site-directed mutagenesis services. Researchers in academia, pharmaceutical companies, and biotech firms rely on these services to create specific genetic variants for functional studies, protein engineering, therapeutic development, and other research purposes.

Customization and Specialization: As the field of genetics becomes more specialized, site-directed mutagenesis service providers may focus on offering tailored solutions to meet the specific needs of different research areas or industries. This could involve expertise in specific organisms, gene families, or targeted genetic modifications.

Automation and High-throughput Capabilities: To improve efficiency and cost-effectiveness, site-directed mutagenesis services may adopt automation and high-throughput technologies. This allows for the simultaneous generation of multiple mutations or modifications in a faster and more streamlined manner.

Quality Assurance and Validation: Given the critical nature of site-directed mutagenesis in research and product development, there is an increasing emphasis on quality control, validation, and rigorous quality assurance measures by service providers. This ensures accurate and reliable results, which are essential for downstream applications.
I

ntegration with Other Services: Site-directed mutagenesis services may be integrated with other molecular biology services or techniques to offer comprehensive solutions. For example, providers may offer sequencing, gene synthesis, or cloning services alongside site-directed mutagenesis to facilitate a seamless workflow for researchers.

Regulatory Compliance: As the applications of site-directed mutagenesis expand into areas like gene therapy or agricultural biotechnology, adherence to regulatory guidelines and ethical considerations will become increasingly important.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Site-directed Mutagenesis Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • GenScript
  • Eurofins
  • Applied Biological Materials
  • Azenta Life Sciences
  • Thermo Fisher Scientific
  • Bon Opus Biosciences
  • Charles Rive
  • Creative Biogene
  • Synbio Technologies
  • Creative Biolabs
  • NovoPro
  • Bionexus
  • Biotech Desk
  • NorClone
  • Eton Bioscience
  • Syd Labs
  • Genosphere Biotechnologies
  • WZ Biosciences
  • FulenGen
  • GENEWIZ
  • iGene Biotechnology
  • Tsingke
  • AtaGenix
  • Zoonbio Biotechnology

Segment by Type

  • Standard Site-directed Mutagenesis Service
  • Customized Site-directed Mutagenesis Service

Segment by Application

  • Scientific Research
  • Gene Therapy
  • Cell Therapy
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Site-directed Mutagenesis Service report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Site-directed Mutagenesis Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Standard Site-directed Mutagenesis Service
1.2.3 Customized Site-directed Mutagenesis Service
1.3 Market by Application
1.3.1 Global Site-directed Mutagenesis Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Scientific Research
1.3.3 Gene Therapy
1.3.4 Cell Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Site-directed Mutagenesis Service Market Perspective (2018-2029)
2.2 Site-directed Mutagenesis Service Growth Trends by Region
2.2.1 Global Site-directed Mutagenesis Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Site-directed Mutagenesis Service Historic Market Size by Region (2018-2023)
2.2.3 Site-directed Mutagenesis Service Forecasted Market Size by Region (2024-2029)
2.3 Site-directed Mutagenesis Service Market Dynamics
2.3.1 Site-directed Mutagenesis Service Industry Trends
2.3.2 Site-directed Mutagenesis Service Market Drivers
2.3.3 Site-directed Mutagenesis Service Market Challenges
2.3.4 Site-directed Mutagenesis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Site-directed Mutagenesis Service Players by Revenue
3.1.1 Global Top Site-directed Mutagenesis Service Players by Revenue (2018-2023)
3.1.2 Global Site-directed Mutagenesis Service Revenue Market Share by Players (2018-2023)
3.2 Global Site-directed Mutagenesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Site-directed Mutagenesis Service Revenue
3.4 Global Site-directed Mutagenesis Service Market Concentration Ratio
3.4.1 Global Site-directed Mutagenesis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Site-directed Mutagenesis Service Revenue in 2022
3.5 Site-directed Mutagenesis Service Key Players Head office and Area Served
3.6 Key Players Site-directed Mutagenesis Service Product Solution and Service
3.7 Date of Enter into Site-directed Mutagenesis Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Site-directed Mutagenesis Service Breakdown Data by Type
4.1 Global Site-directed Mutagenesis Service Historic Market Size by Type (2018-2023)
4.2 Global Site-directed Mutagenesis Service Forecasted Market Size by Type (2024-2029)
5 Site-directed Mutagenesis Service Breakdown Data by Application
5.1 Global Site-directed Mutagenesis Service Historic Market Size by Application (2018-2023)
5.2 Global Site-directed Mutagenesis Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Site-directed Mutagenesis Service Market Size (2018-2029)
6.2 North America Site-directed Mutagenesis Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Site-directed Mutagenesis Service Market Size by Country (2018-2023)
6.4 North America Site-directed Mutagenesis Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Site-directed Mutagenesis Service Market Size (2018-2029)
7.2 Europe Site-directed Mutagenesis Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Site-directed Mutagenesis Service Market Size by Country (2018-2023)
7.4 Europe Site-directed Mutagenesis Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Site-directed Mutagenesis Service Market Size (2018-2029)
8.2 Asia-Pacific Site-directed Mutagenesis Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Site-directed Mutagenesis Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Site-directed Mutagenesis Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Site-directed Mutagenesis Service Market Size (2018-2029)
9.2 Latin America Site-directed Mutagenesis Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Site-directed Mutagenesis Service Market Size by Country (2018-2023)
9.4 Latin America Site-directed Mutagenesis Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Site-directed Mutagenesis Service Market Size (2018-2029)
10.2 Middle East & Africa Site-directed Mutagenesis Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Detail
11.1.2 GenScript Business Overview
11.1.3 GenScript Site-directed Mutagenesis Service Introduction
11.1.4 GenScript Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.1.5 GenScript Recent Development
11.2 Eurofins
11.2.1 Eurofins Company Detail
11.2.2 Eurofins Business Overview
11.2.3 Eurofins Site-directed Mutagenesis Service Introduction
11.2.4 Eurofins Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.2.5 Eurofins Recent Development
11.3 Applied Biological Materials
11.3.1 Applied Biological Materials Company Detail
11.3.2 Applied Biological Materials Business Overview
11.3.3 Applied Biological Materials Site-directed Mutagenesis Service Introduction
11.3.4 Applied Biological Materials Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.3.5 Applied Biological Materials Recent Development
11.4 Azenta Life Sciences
11.4.1 Azenta Life Sciences Company Detail
11.4.2 Azenta Life Sciences Business Overview
11.4.3 Azenta Life Sciences Site-directed Mutagenesis Service Introduction
11.4.4 Azenta Life Sciences Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.4.5 Azenta Life Sciences Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Bon Opus Biosciences
11.6.1 Bon Opus Biosciences Company Detail
11.6.2 Bon Opus Biosciences Business Overview
11.6.3 Bon Opus Biosciences Site-directed Mutagenesis Service Introduction
11.6.4 Bon Opus Biosciences Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.6.5 Bon Opus Biosciences Recent Development
11.7 Charles Rive
11.7.1 Charles Rive Company Detail
11.7.2 Charles Rive Business Overview
11.7.3 Charles Rive Site-directed Mutagenesis Service Introduction
11.7.4 Charles Rive Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.7.5 Charles Rive Recent Development
11.8 Creative Biogene
11.8.1 Creative Biogene Company Detail
11.8.2 Creative Biogene Business Overview
11.8.3 Creative Biogene Site-directed Mutagenesis Service Introduction
11.8.4 Creative Biogene Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.8.5 Creative Biogene Recent Development
11.9 Synbio Technologies
11.9.1 Synbio Technologies Company Detail
11.9.2 Synbio Technologies Business Overview
11.9.3 Synbio Technologies Site-directed Mutagenesis Service Introduction
11.9.4 Synbio Technologies Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.9.5 Synbio Technologies Recent Development
11.10 Creative Biolabs
11.10.1 Creative Biolabs Company Detail
11.10.2 Creative Biolabs Business Overview
11.10.3 Creative Biolabs Site-directed Mutagenesis Service Introduction
11.10.4 Creative Biolabs Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.10.5 Creative Biolabs Recent Development
11.11 NovoPro
11.11.1 NovoPro Company Detail
11.11.2 NovoPro Business Overview
11.11.3 NovoPro Site-directed Mutagenesis Service Introduction
11.11.4 NovoPro Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.11.5 NovoPro Recent Development
11.12 Bionexus
11.12.1 Bionexus Company Detail
11.12.2 Bionexus Business Overview
11.12.3 Bionexus Site-directed Mutagenesis Service Introduction
11.12.4 Bionexus Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.12.5 Bionexus Recent Development
11.13 Biotech Desk
11.13.1 Biotech Desk Company Detail
11.13.2 Biotech Desk Business Overview
11.13.3 Biotech Desk Site-directed Mutagenesis Service Introduction
11.13.4 Biotech Desk Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.13.5 Biotech Desk Recent Development
11.14 NorClone
11.14.1 NorClone Company Detail
11.14.2 NorClone Business Overview
11.14.3 NorClone Site-directed Mutagenesis Service Introduction
11.14.4 NorClone Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.14.5 NorClone Recent Development
11.15 Eton Bioscience
11.15.1 Eton Bioscience Company Detail
11.15.2 Eton Bioscience Business Overview
11.15.3 Eton Bioscience Site-directed Mutagenesis Service Introduction
11.15.4 Eton Bioscience Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.15.5 Eton Bioscience Recent Development
11.16 Syd Labs
11.16.1 Syd Labs Company Detail
11.16.2 Syd Labs Business Overview
11.16.3 Syd Labs Site-directed Mutagenesis Service Introduction
11.16.4 Syd Labs Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.16.5 Syd Labs Recent Development
11.17 Genosphere Biotechnologies
11.17.1 Genosphere Biotechnologies Company Detail
11.17.2 Genosphere Biotechnologies Business Overview
11.17.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Introduction
11.17.4 Genosphere Biotechnologies Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.17.5 Genosphere Biotechnologies Recent Development
11.18 WZ Biosciences
11.18.1 WZ Biosciences Company Detail
11.18.2 WZ Biosciences Business Overview
11.18.3 WZ Biosciences Site-directed Mutagenesis Service Introduction
11.18.4 WZ Biosciences Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.18.5 WZ Biosciences Recent Development
11.19 FulenGen
11.19.1 FulenGen Company Detail
11.19.2 FulenGen Business Overview
11.19.3 FulenGen Site-directed Mutagenesis Service Introduction
11.19.4 FulenGen Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.19.5 FulenGen Recent Development
11.20 GENEWIZ
11.20.1 GENEWIZ Company Detail
11.20.2 GENEWIZ Business Overview
11.20.3 GENEWIZ Site-directed Mutagenesis Service Introduction
11.20.4 GENEWIZ Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.20.5 GENEWIZ Recent Development
11.21 iGene Biotechnology
11.21.1 iGene Biotechnology Company Detail
11.21.2 iGene Biotechnology Business Overview
11.21.3 iGene Biotechnology Site-directed Mutagenesis Service Introduction
11.21.4 iGene Biotechnology Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.21.5 iGene Biotechnology Recent Development
11.22 Tsingke
11.22.1 Tsingke Company Detail
11.22.2 Tsingke Business Overview
11.22.3 Tsingke Site-directed Mutagenesis Service Introduction
11.22.4 Tsingke Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.22.5 Tsingke Recent Development
11.23 AtaGenix
11.23.1 AtaGenix Company Detail
11.23.2 AtaGenix Business Overview
11.23.3 AtaGenix Site-directed Mutagenesis Service Introduction
11.23.4 AtaGenix Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.23.5 AtaGenix Recent Development
11.24 Zoonbio Biotechnology
11.24.1 Zoonbio Biotechnology Company Detail
11.24.2 Zoonbio Biotechnology Business Overview
11.24.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Introduction
11.24.4 Zoonbio Biotechnology Revenue in Site-directed Mutagenesis Service Business (2018-2023)
11.24.5 Zoonbio Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock